risk of recurrence

  • October 1, 2019  

    Surgical Technique Lowers Right-Sided Colon Ca Recurrence Risk Bookmark

    George Lundberg, MD

    Article from MedPage Today curated by Editor in Chief George Lundberg, MD, who notes: 

    Surgery is the primary treatment of choice for colorectal cancer. This enhanced  resection technique improves survival.

    Go to full article published by MedPage Today.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  • January 7, 2019  

    Roche’s Kadcyla Cuts Risk of Breast Cancer Recurrence After Surgery Bookmark

    Emma Shtivelman, PhD

    Excerpt:

    “Roche’s Kadcyla was significantly better than Herceptin at reducing the risk of breast cancer recurrence in certain patients with residual disease after surgery, according to new study findings presented at the San Antonio Breast Cancer Symposium.

    “Data from the Phase III KATHERINE study show that Kadcyla (trastuzumab emtansine) as a single agent significantly reduced the risk of disease recurrence or death by 50% compared to Herceptin (trastuzumab) as an adjuvant (after surgery) treatment in people with HER2-positive early breast cancer (eBC) who have residual disease following neoadjuvant therapy.”

    Go to full article published by PharmaTimes on Dec 6, 2018.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  • October 30, 2015  

    To Type or to Print? Oncotype DX and Mamma/BluePrint Tests for Breast Cancer

    Emma Shtivelman, PhD

    Women diagnosed with localized breast cancer face difficult decisions with their doctors. What kind of neoadjuvant (before surgery) treatment to choose? Should chemotherapy follow surgery? Based on the subtype of breast cancer, should specific chemotherapy drugs be used?